SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-012124
Filing Date
2022-05-12
Accepted
2022-05-12 16:05:54
Documents
102
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20220331_10q.htm   iXBRL 10-Q 1233464
7 EXHIBIT 31.1 ex_369607.htm EX-31.1 7775
8 EXHIBIT 31.2 ex_369608.htm EX-31.2 7950
9 EXHIBIT 32.1 ex_369609.htm EX-32.1 3820
10 EXHIBIT 32.2 ex_369610.htm EX-32.2 3792
  Complete submission text file 0001437749-22-012124.txt   8095806

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20220331.xsd EX-101.SCH 97629
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20220331_cal.xml EX-101.CAL 55322
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220331_def.xml EX-101.DEF 581612
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220331_lab.xml EX-101.LAB 489181
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220331_pre.xml EX-101.PRE 625485
96 EXTRACTED XBRL INSTANCE DOCUMENT nby20220331_10q_htm.xml XML 1332832
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 22917739
SIC: 2834 Pharmaceutical Preparations